Related Experiment Video
Updated: Aug 14, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance
T I Nicas1, M L Zeckel, D K Braun
1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. nicas_thalia_r@lilly.com
Abstract:
The incidence of infections caused by resistant Gram-positive pathogens is increasing, while emergence of vancomycin resistance is reducing the number of therapeutic options. New agents are being rapidly evaluated as candidates to replace vancomycin; some of the most promising include semisynthetic glycopeptides, quinupristin-dalfopristin, oxazolidinones and everninomycins. Alternative strategies, including immunization and therapeutic vaccines, may also have a role.
More Related Videos
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance

